Edition:
Deutschland

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

127.15EUR
30 Oct 2020
Change (% chg)

€-5.35 (-4.04%)
Prev Close
€132.50
Open
€130.50
Day's High
€131.05
Day's Low
€126.70
Volume
709,701
Avg. Vol
443,706
52-wk High
€137.25
52-wk Low
€76.22

About

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and... (more)

Buy/Sell

Sell Hold Buy
2.26 Mean rating from 23 analysts

Overall

Beta: 0.58
Market Cap(Mil.): €16,433.15
Shares Outstanding(Mil.): 129.24
Dividend: 1.30
Yield (%): 1.02

UPDATE 3-EU must wean itself off Asia for key drug ingredients

BERLIN, Oct 7 European drugmakers will struggle to bring production back to the region, but the industry needs to diversify supplies to avoid shortages, a top EU official said on Wednesday, as worries grow about Asia's dominance of the generic ingredients market.

Majority of generic drug ingredients produced in Asia - study

* Only a few manufacturers worldwide for more than half of APIs

Merck KGaA says it has overcome production shortages in vaccine materials

* Life Science unit has invested more than 425 mln eur since 2017

Photo

Germany's Merck says it will focus on smaller takeovers

FRANKFURT German drugs and chemicals maker Merck KGaA said on Wednesday it would until 2022 focus on cutting its debt from the takeover of electronic materials company Versum and any acquisitions thereafter would likely be smaller ones.

Germany's Merck says it will focus on smaller takeovers

FRANKFURT German drugs and chemicals maker Merck KGaA said on Wednesday it would until 2022 focus on cutting its debt from the takeover of electronic materials company Versum and any acquisitions thereafter would likely be smaller ones.

Germany's Merck says it will focus on smaller takeovers

FRANKFURT, Sept 16 German drugs and chemicals maker Merck KGaA said on Wednesday it would until 2022 focus on cutting its debt from the takeover of electronic materials company Versum and any acquisitions thereafter would likely be smaller ones.

Photo

Sulzer buys self-injection pen maker to bolster under-pressure applicators unit

ZURICH Swiss oil pumps-to-aerators group Sulzer will buy drug delivery device maker Haselmeier for 100 million euros (90 million pounds) and aims to double its sales over the next five years.

Photo

Sulzer buys self-injection pen maker to bolster under-pressure applicators unit

ZURICH Swiss oil pumps-to-aerators group Sulzer will buy drug delivery device maker Haselmeier for 100 million euros ($118 million) and aims to double its sales over the next five years.

UPDATE 2-Sulzer buys self-injection pen maker to bolster under-pressure applicators unit

ZURICH, Aug 24 Swiss oil pumps-to-aerators group Sulzer will buy drug delivery device maker Haselmeier for 100 million euros ($118 million) and aims to double its sales over the next five years.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.22%
Rohstoffe -0.82%
Industrie -2.33%
Konjunktur abhängige Waren & Dienstleistungen -0.51%
Konjunktur unabhängige Waren & Dienstleistungen +0.06%
Finanzindustrie -0.79%
Pharma -2.12%
Technologie +0.00%